 The stock price of Prothena Corporation NASDAQ: PRTA, a biotechnology company focused on treatment of diseases that involve protein misfolding or cell adhesion, has seen a a large 13 drop over the last five trading days. The decline in PRTA stock came after another pharmaceuticals company. 